Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 17/20 | 0.40 |
| ▸ | HCRTR2 | O43614 | 16/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | ADAMTS7 | Q9UKP4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23354698 | 0.87 | ADAMTS7 (0.38) | HCRTR1HCRTR2PLAUELANECES2 | |
| SCHEMBL23354796 | 0.86 | ADAMTS7 (0.47) | ADAMTS7 | |
| SCHEMBL29597179 | 0.83 | HCRTR1 (0.49) | HCRTR1HCRTR2CES2CES1 | |
| SCHEMBL1586205 | 0.83 | HCRTR1 (0.49) | HCRTR1HCRTR2CES2CES1 | |
| SCHEMBL15639716 | 0.81 | KDM4E (0.38) | HCRTR1HCRTR2PLAUELANECES2 | |
| Iodomethane SCHEMBL31482883 | 0.79 | HCRTR1 (0.48) | HCRTR1HCRTR2 | |
| SCHEMBL23354732 | 0.75 | KMO (0.38) | CES2CES1ADAMTS7 | |
| SCHEMBL23354661 | 0.75 | KMO (0.41) | CES2CES1 | |
| SCHEMBL23354899 | 0.74 | ALDH1A1 (0.52) | — | |
| SCHEMBL23354846 | 0.74 | ADORA2A (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021023843-A1 | IMPROVED SYNTHETIC METHODS OF MAKING (2H-1,2,3-TRIAZOL-2-YL)PHENYL COMPOUNDS AS OREXIN RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2021-02-11 | — | — | WO | disclosed |